Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
patients
100%
cancer
78%
pancreas
67%
thrombin
39%
blood
34%
thrombosis
34%
adenocarcinomas
29%
therapy
28%
risks
21%
surgery
20%
plasma
15%
data
14%
chemotherapy
13%
blood coagulation
11%
conferences
11%
phenotype
11%
fibrinolysis
11%
plasmin
11%
administration
11%
devices
11%
combined therapy
11%
blood cells
9%
control
8%
liver
8%
comparative evaluations
7%
capacity
7%
diseases
6%
ports
6%
mortality
6%
peaks
6%
Keyphrases
Thrombin Generation
42%
Pancreatic Cancer
33%
Whole Blood
33%
Pancreatic Ductal Adenocarcinoma
32%
Decompensated Cirrhosis
22%
Thrombosis
20%
Venous Thromboembolism
19%
Coagulation
17%
Cirrhosis
17%
Bleeding
14%
In Cancer
13%
Platelets
13%
Cardiovascular Disease
12%
Platelet-poor Plasma
11%
Evolving Data
11%
Cardiovascular Complications
11%
Blood Coagulation
11%
Venous Thrombosis
11%
Hypocoagulability
11%
Cellular Components
11%
Primary Prophylaxis
11%
Position Paper
11%
Maastricht
11%
Cancer Care
11%
Consensus Conference
11%
Prothrombotic Phenotype
11%
Disbalance
11%
Fibrinolysis
11%
Plasmin Generation
11%
Randomized Controlled Trial
11%
Medicine and Dentistry
Pancreas Cancer
33%
Thrombin
22%
Pancreas Adenocarcinoma
22%
Decompensated Liver Cirrhosis
22%
Thrombosis
19%
Venous Thromboembolism
16%
Bleeding
15%
Malignant Neoplasm
14%
Cardiovascular Disease
12%
Thrombocyte Poor Plasma
12%
Thromboprophylaxis
11%
Phlebothrombosis
11%
Blood Clotting
11%
Hypocoagulability
11%
Randomized Controlled Trial
11%
Neoadjuvant Therapy
11%
Postoperative Complication
11%
Liver Cirrhosis
9%
Gemcitabine
7%
Radiation Therapy
6%
Pancreatectomy
5%
Chemoradiotherapy
5%
Coagulopathy
5%
Thrombomodulin
5%
